Blossom Pharmaceuticals FDA Record
- Latest inspection OAI · Apr 11, 2025
- No warning letters matched by name
Blossom Pharmaceuticals has 13 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Blossom Pharmaceuticals" is on file. FDA has published 1 Form 483 for Blossom Pharmaceuticals.
- Latest recall
- D-0210-2026 · Class II · Oct 31, 2025
- Latest inspection
- Apr 11, 2025 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 13 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 3 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Blossom Pharmaceuticals: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 1 | 0 | 13 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Blossom Pharmaceuticals as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Blossom Pharmaceuticals yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Blossom Pharmaceuticals Form 483s
| Date | Document | FEI |
|---|---|---|
| Apr 11, 2025 · Document on fda.gov | 483 | 3010806039 |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0210-2026 | Class II | Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals… | Oct 31, 2025 |
| D-0203-2026 | Class II | Wecare Enema, 4.5 Fl Oz/133mL, Manufactured for: Dynarex Corporation, 11 Dynarex Corporation… | Oct 31, 2025 |
| D-0206-2026 | Class II | Nivagen Pharmaceuticals, Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protectant, Net Wt. 15 oz… | Oct 31, 2025 |
| D-0201-2026 | Class II | Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street… | Oct 31, 2025 |
| D-0212-2026 | Class II | Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant, Net Wt. 2 oz (56.7 g), Distributed by… | Oct 31, 2025 |
| D-0204-2026 | Class II | Dynagel, Moisturizing Wound Hydrogel, Net Wt. 3oz (84.7 g), Manufactured for: Dynarex Corporation… | Oct 31, 2025 |
| D-0209-2026 | Class II | Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals… | Oct 31, 2025 |
| D-0208-2026 | Class II | Nivagen, Zinc Oxide Ointment, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA… | Oct 31, 2025 |
| D-0205-2026 | Class II | WeCare, Zinc Oxide Ointment, Net Wt. 15 oz/425 g, Manuactured for: Dynarex Corporation, 11 Dynarex… | Oct 31, 2025 |
| D-0211-2026 | Class II | Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Distributed by: Trifecta… | Oct 31, 2025 |
| D-0207-2026 | Class II | Dynashield, 4 oz cream (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street… | Oct 31, 2025 |
| D-0213-2026 | Class II | Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street… | Oct 31, 2025 |
| D-0202-2026 | Class II | Dynashield Skin Protectant, Net Wt. 16 oz (453.6 g), Manufactured for: Dyrnarex Corporation, 10… | Oct 31, 2025 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Apr 11, 2025 | Bardej, Goa, India | Drugs | Official Action Indicated (OAI) | 3010806039 |
| Feb 14, 2019 | Bardej, Goa, India | Drugs | Voluntary Action Indicated (VAI) | 3010806039 |
| Dec 16, 2016 | Bardej, Goa, India | Drugs | Voluntary Action Indicated (VAI) | 3010806039 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3010806039 | Bardej, Goa, India | 3 | Apr 11, 2025 |
Blossom Pharmaceuticals and the FDA: common questions
Has Blossom Pharmaceuticals received an FDA warning letter?
No FDA warning letter addressed to the name "Blossom Pharmaceuticals" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Blossom Pharmaceuticals received an FDA Form 483?
FDA has published 1 Form 483 for Blossom Pharmaceuticals in its reading room, the most recent dated Apr 11, 2025. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Blossom Pharmaceuticals?
The most recent FDA inspection on file ended Apr 11, 2025 at Bardej, Goa, India and was classified OAI. FDA has 3 inspections of Blossom Pharmaceuticals on file, 1 of them classified OAI (official action indicated).
Has Blossom Pharmaceuticals had an FDA recall?
Yes. Blossom Pharmaceuticals has 13 FDA recalls on record. The most recent started Oct 31, 2025.
Need more than this page shows? Ask about Blossom Pharmaceuticals in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.